InspireMD (NSPR) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for InspireMD (NSPR) over the last 4 years, with Q3 2025 value amounting to -$0.17.
- InspireMD's EPS (Weighted Average and Diluted) fell 625.0% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year decrease of 1527.78%. This contributed to the annual value of -$0.76 for FY2024, which is 691.15% up from last year.
- Per InspireMD's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.17 for Q3 2025, which was down 625.0% from -$0.26 recorded in Q2 2025.
- InspireMD's 5-year EPS (Weighted Average and Diluted) high stood at -$0.13 for Q4 2023, and its period low was -$0.6 during Q4 2022.
- For the 4-year period, InspireMD's EPS (Weighted Average and Diluted) averaged around -$0.31, with its median value being -$0.22 (2024).
- As far as peak fluctuations go, InspireMD's EPS (Weighted Average and Diluted) skyrocketed by 7833.33% in 2023, and later tumbled by 7184.99% in 2024.
- Quarter analysis of 4 years shows InspireMD's EPS (Weighted Average and Diluted) stood at -$0.6 in 2022, then surged by 78.33% to -$0.13 in 2023, then crashed by 71.85% to -$0.22 in 2024, then increased by 23.9% to -$0.17 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.17 for Q3 2025, versus -$0.26 for Q2 2025 and -$0.22 for Q1 2025.